355 related articles for article (PubMed ID: 12700961)
1. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
3. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P; Bagga A; Jindal N; Srivastava RN
Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
[TBL] [Abstract][Full Text] [Related]
4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.
Mantan M; Sriram CS; Hari P; Dinda A; Bagga A
Pediatr Nephrol; 2008 Sep; 23(9):1495-502. PubMed ID: 18566839
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Plank C; Kalb V; Hinkes B; Hildebrandt F; Gefeller O; Rascher W;
Pediatr Nephrol; 2008 Sep; 23(9):1483-93. PubMed ID: 18481113
[TBL] [Abstract][Full Text] [Related]
9. Late resistance to corticosteroids in nephrotic syndrome.
Srivastava RN; Agarwal RK; Moudgil A; Bhuyan UN
J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
[TBL] [Abstract][Full Text] [Related]
10. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis.
Rennert WP; Kala UK; Jacobs D; Goetsch S; Verhaart S
Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995
[TBL] [Abstract][Full Text] [Related]
11. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[TBL] [Abstract][Full Text] [Related]
12. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
15. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[TBL] [Abstract][Full Text] [Related]
16. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF; Farine M; Thorner P; Baumal R
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
18. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis?
Mitwalli AH
Nephrol Dial Transplant; 1998 Jun; 13(6):1524-8. PubMed ID: 9641186
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
20. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
Prasad N; Gulati S; Sharma RK; Singh U; Ahmed M
Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
